SwanBio Therapeutics Limited

POWERING A MOVEMENT

Development of pharmaceutical preparations for use in gene therapy; genetic engineering and biotechnology research; research and development of new products in the field of gene therapeutics; scientific and medical research in the field of genetics, gene therapy and genetic engineering; laboratory research in the fields of genetics, gene therapy, drug development, biotechnology, microbiology and molecular biology; pharmaceutical drug and gene therapy discovery and drug/therapeutic development; biological research and development; research and development of new products in the field of gene therapeutics in neurological diseases;

S

The mark consists of a stylized S in the shape of a swan's wing.;Therapeutic compositions comprised of adeno-associated viral (AAV) vectors and recombinant adeno-associated viral (rAAV) vectors for therapeutic effect in gene therapy, namely, gene inhibition therapy and/or RNA interference (RNAi); Therapeutic compositions comprised of adeno-associated viral (AAV) vectors and recombinant adeno-associated viral (rAAV) vectors for therapeutic effect in gene therapy, namely, gene augmentation therapy; Therapeutic compositions comprised of adeno-associated viral (AAV) vectors and recombinant adeno-associated viral (rAAV) vectors for therapeutic effect in gene therapies using intrathecal administration; Biologic preparations for use in the treatment of genetically based diseases and disorders; Biologic preparations for medical purposes, namely, for gene therapy for treating genetic disorders; Pharmaceutical preparations that modulate RNA expression for the treatment of neurological diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene inhibition and gene augmentation; Viruses, viral vectors and viral constructs for the treatment of neurological diseases and disorders and genetic diseases and disorders; Pharmaceutical preparations for gene therapy; pharmaceutical and biopharmaceutical agents for the treatment of genetic disorders and neurological diseases and disorders; Pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders and neurological diseases and disorders; Pharmaceutical preparations, namely, DNA and/or RNA therapeutics for the treatment of genetic disorders and neurological diseases and disorders;Development of pharmaceutical preparations for use in gene therapy; Genetic engineering and biotechnology research; Research and development of new products in the field of gene therapeutics; Scientific and medical research in the field of genetics, gene therapy and genetic engineering; Laboratory research in the fields of genetics, gene therapy, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug and gene therapy discovery and drug/therapeutic development; Biological research and development;